Slovenian research institute is looking for a consortium for the Horizon topic Tackling Antimicrobial Resistance

Summary

Profile Type: Research & Development Request
POD Reference: RDRSI20240223002
Term of Validity: 23 February 2024 - 22 February 2025
Company's Country: Slovenia
Type of partnership: Research and development cooperation agreement
Targeted Countries: All countries

Contact the EEN partner nearest to you for more information.

Find my local partner

General information

Short Summary: The Slovenian research institute has developed a fast and high throughput method for evaluating antibacterial and anti-biofilm activities, which is important to evaluate novel antimicrobials. The institute would like to integrate in a consortium as partner on Horizon Europe Call under topic HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage ‘Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials’ (deadline 04 April 2024).
Full Description: More than 700,000 people die each year due to drug resistant infections, and it is estimated that this number could increase to 10 million people per year by 2050. Altogether, food-borne illnesses represent a global public health problem that affects an estimated 600 million people annually (WHO). The search for new active compounds with antimicrobial and anti-biofilm activities requires extensive screening studies. Biofilm formation is a persistence strategy for microorganisms, and has a role for colonization of both abiotic and biotic surfaces. Control of biofilm formation might represent a better option in the fight against bacteria, especially due to increasing occurrence of antimicrobial resistance (AMR). To avoid the disastrous impact of AMR we urgently need alternative strategies for combating infectious diseases. Moreover, precise understanding of mechanisms of action and distinguishing between antimicrobial versus anti-biofilm activities will enable us to better control the spread of AMR and help reduce its occurrence. None of the existing methods can simultaneously determine antimicrobial and anti-biofilm activities in a relatively short time.

A Slovenian research institute and university have developed a fast and high throughput method for evaluating antibacterial and anti-biofilm activities. The method involves determining the growth of the microorganisms by measuring the optical density in intervals during the incubation. The method could be applied as a software application alone or as a part of a spectrophotometer used for antibacterial and anti-biofilm measurement.
The institute has extensive experience in microbial biotechnology and food microbiology.

The institute is looking for a coordinator with a consortium that is planning to submit a proposal for the Horizon Europe Call under topic HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage ‘Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials’.
Advantages and Innovations: None of the existing methods can simultaneously determine antimicrobial and anti-biofilm activities in a relatively short time. The method enables simultaneous detection and differentiation of the antimicrobial and/or anti-biofilm activities of a composition or a compound analysed in less than 20 hours.
Stage of Development: Lab tested
Sustainable Development Goals: Goal 3: Good Health and Well-being

Partner Sought

Expected Role of a Partner: Consortium and coordinator for the identified call.
Type and Size of Partner: Big companyOtherSME 11-49SME 50 - 249R&D InstitutionUniversity
Type of partnership: Research and development cooperation agreement

Call details

Framework program: Horizon Europe
Call title and identifier: Tackling Antimicrobial Resistance (AMR) through R&D in novel and existing antimicrobials
HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage
Submission and evaluation scheme: two-stage
Coordinator required: Yes
Deadline for EoI: 28 Mar 2024
Deadline of the call: 4 Apr 2024
Web link to the call: https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportuni…

Dissemination

Technology keywords: 06001005 - Diagnostics, Diagnosis08002002 - Food Microbiology / Toxicology / Quality Control06002008 - Microbiology06001018 - Virus, Virology/Antibiotics/Bacteriology06001015 - Pharmaceutical Products / Drugs
Market keywords: 04010 - Microbiology05007002 - Pharmaceuticals/fine chemicals04009 - In vitro Testing, Trials05007006 - Computer-aided diagnosis and therapy05001002 - In-vitro diagnostics
Sector Groups Involved: Health
Targeted countries: All countries